Compared with those ET and PMF patients with JAK2 V617F or MPL mutations, the CALR mutant patients showed a lower white blood cell count (P = 0.0061), elevated platelet (P = 0.0168) and younger age (P = 0.0002). This evidence concerns the gene CALR and essential thrombocythemia.